Stanozolol Depot Research Overview
Stanozolol Depot is a synthetic anabolic androgenic steroid derivative of dihydrotestosterone, formulated as a 50mg/ml injectable suspension for in-vitro laboratory research applications. This water-based depot formulation provides researchers with a standardised reference compound for investigating androgen receptor binding mechanisms and anabolic pathway modulation in controlled experimental settings. The compound demonstrates distinct pharmacological properties compared to its oral counterpart, offering researchers enhanced bioavailability characteristics for comprehensive androgenic studies. Laboratory investigations utilising this preparation enable detailed analysis of steroid hormone receptor interactions and downstream signalling cascades. Researchers at Stroid UK Shop can access this pharmaceutical-grade material for advancing their understanding of androgenic compound mechanisms.
Laboratory Research Applications
Research teams study Stanozolol Depot to examine its selective androgenic properties and tissue-specific effects in experimental models. The injectable formulation allows researchers to investigate depot release kinetics and pharmacokinetic profiles under controlled laboratory conditions. Scientists analyse this compound’s interaction with androgen receptors to understand binding affinity variations and downstream gene expression modifications. Comparative studies evaluate this steroid’s anabolic index relative to other androgenic compounds available in our Stanozolol research category. Metabolic research applications focus on examining hepatic enzyme interactions and lipid profile modifications. Advanced researchers combine this compound with other research chemicals from our SARM collection and peptide inventory to investigate synergistic molecular pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Compound | Stanozolol (17α-methyl-5α-androst-2-eno[3,2-c]pyrazol-17β-ol) |
| CAS Number | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Concentration | 50mg/ml |
| Volume | 1ml per ampoule |
| Package Count | 10 ampoules |
| Storage Requirements | Room temperature, protect from light |
Research Compliance Standards
This Stanozolol Depot preparation is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, veterinary applications, or therapeutic use. Researchers must maintain appropriate laboratory safety protocols when handling this androgenic compound and ensure compliance with institutional research guidelines. All experimental work should be conducted in accredited research facilities with proper waste disposal procedures. This product is restricted to qualified research personnel conducting legitimate scientific investigations into steroid hormone mechanisms and androgenic pathway studies.
